Ekso Bionics Holdings Inc (EKSO)

[abira]

Matters to be voted on at today's shareholders meeting:

1. To elect six directors, all of whom are currently serving on our Board of Directors, to serve until the annual meeting of stockholders to be held in 2019 and until their respective successors are elected and qualified, or until his or her earlier death, resignation or removal;
2. To ratify an amendment to our Articles of Incorporation approved by the stockholders of the Company on December 21, 2017 to increase the total number of authorized shares of common stock from 71,428,571 shares to 141,428,571 shares;
3. To ratify an amendment to our Amended and Restated 2014 Equity Incentive Plan approved by the stockholders of the Company on December 21, 2017 to increase the number of shares available for grant under such Plan from 4,714,285 shares to 9,114,285 shares;
4. To ratify the appointment of OUM & Co., LLP as the Company’s independent auditors for the year ending December 31, 2018;
5. To approve, in an advisory (non-binding) vote, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement;
6. To approve, in an advisory (non-binding) vote, whether a non-binding, advisory vote on the compensation of the Company’s named executive officers should occur every one, two or three years; and
7. To transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.

As Skep pointed out, for details, check the 14A from April 30th, 2018: https://ir.eksobionics.com/all-sec-filings#document-12303-0001140361-18-020401